Johnson & Johnson
JNJ · NYSE
9/28/2025 | 6/29/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $441 | $370 | $399 | $348 |
| - Cash | $18 | $19 | $38 | $24 |
| + Debt | $6 | $51 | $52 | $37 |
| Enterprise Value | $429 | $402 | $413 | $361 |
| Revenue | $24 | $24 | $22 | $23 |
| % Growth | 1.1% | 8.5% | -2.8% | – |
| Gross Profit | $17 | $16 | $15 | $15 |
| % Margin | 69.6% | 67.9% | 66.4% | 68.3% |
| EBITDA | $9 | $9 | $16 | $6 |
| % Margin | 38.7% | 36.8% | 71.3% | 26.3% |
| Net Income | $5 | $6 | $11 | $3 |
| % Margin | 21.5% | 23.3% | 50.2% | 15.2% |
| EPS Diluted | 2.12 | 2.29 | 4.54 | 1.41 |
| % Growth | -7.4% | -49.6% | 222% | – |
| Operating Cash Flow | $9 | $4 | $4 | $7 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$2 |
| Free Cash Flow | $8 | $2 | $3 | $5 |